171 filings
Page 4 of 9
8-K
x9p cu2knr43sm
11 Feb 21
Other Events
5:01pm
8-K
1yufiuq
31 Dec 20
Entry into a Material Definitive Agreement
4:31pm
8-K
s17zm
2 Nov 20
Regulation FD Disclosure
9:22am
8-K
18z9n8kxzsmdrvisbon
30 Oct 20
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection
8:00am
8-K
1j54b9
13 Aug 20
Trevena Announces Pricing of $50 Million Public Offering of Common Stock
12:00am
8-K
eiwra6 1qqzrcgv5c
11 Aug 20
Trevena Announces Proposed Public Offering of Common Stock
4:28pm
8-K
2oevrjy2g80 k3
10 Aug 20
Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection
6:24am
8-K
gvphl smia
2 Jun 20
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
7:00am
8-K
9my6ilsm 5y6lqhncshr
26 May 20
Other Events
4:05pm
8-K
c35ug6 8gs9qkfylqn
18 May 20
Regulation FD Disclosure
5:21pm
8-K
gigoykrboz xayw
18 May 20
Regulation FD Disclosure
7:00am
8-K
ewyiv1f1w
15 May 20
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
izgzk74
7 May 20
Trevena Reports First Quarter 2020 Results
7:05am
8-K
4nlv 12zxq8db4z
20 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:30am
8-K
qtbvxgh8y6oark
26 Mar 20
Other Events
7:00am
8-K
sbu4bz0b3 zgeduqfg5
13 Mar 20
Trevena Reports Fourth Quarter and Full Year 2019 Results
7:00am
8-K
cye8u
5 Mar 20
FDA considers NDA resubmission a complete Class 2 response
7:05am
8-K
0g1b2fmyayeyunp9tiqq
4 Mar 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
vwz92ydspi1xjywna
14 Feb 20
Trevena Appoints Scott Applebaum as Chief Legal and Compliance Officer and SVP of Regulatory Affairs
4:02pm
8-K
yuz9hh16
10 Feb 20
Other Events
7:06am